EN DE
Watch 1933 Industries Inc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

1933 Industries Inc (TGIFF) fair value: what the stock is really worth

As of Nov 13, 2026: fair value (intrinsic value) of 1933 Industries Inc stock $0.01, price $0.00, upside +37.3%, quality 51 out of 100. Rating: undervalued. Calculated from audited financials with 10 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US · Home Canada · ISIN CA65442F1053

1I 1933 Industries Inc logo Thin data Nov 13, 2026

1933 Industries Inc

TGIFF · US

Cheap (27% below fair value) and solid company, but falling price: meets 2 of 3 rules.

Get notified free when this changes
Fair value $0.0067 · Undervalued 
Generates free cash flow 
Even on cautious assumptions the value is 37% above the price ($0.0067). 
Quality 51/100 
Mixed Growth (revenue 5y +7.8 %/yr in USD) 
Thin margins · 2.8% net margin (TTM) 
Negative equity (buybacks among others) 
Changed on Oct 25: $0.0088 → $0.0072 
Falling price (downtrend) 
Trails peers (3/8) 
Narrow moat 26/100 · thin data
Thin data 
⚠ Thinly traded
Watch 1933 Industries Inc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$0.0810 $0.0027 Fair Value $0.0067 Jun 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 13, 2026.

How to read this chart

60‑month range $0.0027 – $0.0810 · fair‑value band $0.0067 – $0.0073 · the $0.0049 price screens below the $0.0067 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 13, 2026.

Follow 1933 Industries in your weekly email

Every Wednesday you see whether 1933 Industries is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

1933 Industries Inc., together with its subsidiaries, engages in the cultivation, extraction, and production of cannabis products in the United States. It operates through AMA and Infused MFG segments.

Show moreShow less

The company offers craft-style cannabis, branded flower, infused pre-rolls, full spectrum oils, distillates, and blends of terpenes; vaporizer products and boutique concentrate, such as shatter, crumble, batter, sugar wax, diamonds, and cured and live resins under the AMA and Level X brands.

It also provides cannabidiol, and cannabinol infused products. The company sells its products through licensed dispensaries, as well as direct to consumers via e-commerce at cannahemp.com.

The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. 1933 Industries Inc. is headquartered in Vancouver, Canada.

Stock analysis

1933 Industries Inc (TGIFF) currently trades at $0.0049, while our model-based Fair Value estimate is $0.0067, implying the stock looks roughly 27% undervalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of $0.0250 per share, and 10 of the 10 models we run sit above the $0.0049 price.

Bear case: the Multiples group reads lowest at $0.0100, and 0 of the 10 models stay below the price. Data coverage for this calculation is low.

Scenario range: $0.0067 (bear) to $0.0073 (bull), the price of $0.0049 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 51/100 (solid quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

1933 Industries Inc reported revenue of C$17.4M in FY2025 versus C$12.0M in FY2021, a compound +9.9%/yr. Reported net income was −C$217K in FY2025.

Key figures

Market cap $2.6M Micro · P/S ratio 0.21 · Net margin −1.2% · Return on equity −1,143% · Return on assets (EBIT) −17.5% (5-year average) · Operating margin 8.9% · Revenue (TTM) C$16.5M · Revenue growth (YoY) −9.3%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 26 out of 100 (low confidence).

What moves the price

The share trades about 65% below its 52-week high and 26% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at 37%, TGIFF screens cheaper than that median.

Fair Value models

Bear $0.0067 Fair Value $0.0067 Bull $0.0073
Price $0.0049 · Upside +37.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF $0.0200 $0.0300 $0.0400 81
Growth DCF $0.0200 $0.0300 $0.0400 79
5Y Revenue Exit $0.0100 $0.0200 $0.0200 74
All 10 models by family
DCF Models
FCF DCF $0.0200 $0.0300 $0.0400 81
5Y Revenue Exit $0.0100 $0.0200 $0.0200 74
5Y EBITDA Exit $0.0100 $0.0200 $0.0300 73
10Y Revenue Exit $0.0200 $0.0200 $0.0300 68
10Y EBITDA Exit $0.0200 $0.0200 $0.0300 70
Multiples
EV/EBIT $0.0100 $0.0100 $0.0200 63
EV/EBITDA $0.0100 $0.0100 $0.0200 64
EV/Revenue n/a $0.0100 $0.0100 51
Growth DCF
Growth DCF $0.0200 $0.0300 $0.0400 79
Rev-Margin DCF $0.0100 $0.0200 $0.0200 74

Open the full fair value analysis →

Quality Score breakdown

Overall quality 51/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 39
How much profit the company makes from its sales and capital
Quality Growth 58
Are margins and returns getting better?
Cashflow 62
Do the profits arrive as real cash?
Financial strength 4
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 11
How calm the share price moves, does not count
Price momentum 27
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 5
Distance to the 52-week high, does not count
New shares 59
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 50/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−9.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.8%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+42.4%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−139.0% (2020) → 3.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−10.4%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (figures in CAD, Canada: IMF forecast 2.1% a year to 2030, 2.6% from 2016 to 2025) that is about −12.2% a year for the price.

Watch TGIFF, get fair value alerts →

Compare 1933 Industries Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 604 stocks

Beats the industry median on 3/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 51 · Below median
Fair Value upside +37.3% · Top 25%
Profitability
Return on equity (12 months) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets −1.3% · Below median
Net margin (12 months) 2.8% · Below median
Operating margin (12 months) 8.9% · Below median
Growth and dividend
Revenue growth (quarter YoY) −9.3% · Bottom 25%
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (12 months) 0.22× · Cheapest 25%
Price / free cash flow (fiscal year) 2.2× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)83 · sector 19
FUTURE (revenue growth)0 · sector 29
PAST (return on equity)0 · sector 26
HEALTH (low debt)0 · sector 96
DIVIDEND (yield)0 · sector 32

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Zoetis Inc ZTS $83.82 $113.53 +35% vs TGIFF
Jiangsu Hengrui Pharmaceuticals Co 600276 ¥48.02 ¥53.04 +10% vs TGIFF
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,868 ₹1,983 +6% vs TGIFF
Haleon plc HLN $9.17 $8.47 −8% vs TGIFF
Merck KGaA MRK €149.70 €108.83 −27% vs TGIFF
Galderma Group GALD CHF 191.00 CHF 112.30 −41% vs TGIFF
Takeda Pharmaceutical Company TAK $21.43 $11.20 −48% vs TGIFF
Sandoz Group SDZ CHF 84.60 CHF 40.54 −52% vs TGIFF
Teva Pharmaceutical Industries Limited TEVA $44.50 $20.74 −53% vs TGIFF
Divi's Laboratories Limited DIVISLAB ₹11,080 ₹1,567 −86% vs TGIFF

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

1933 Industries Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "1933 Industries Inc Fair Value". https://www.fairvalue-calculator.com/stock/TGIFF

Frequently asked questions

Is 1933 Industries Inc (TGIFF) overvalued or undervalued?
As of Nov 13, 2026, our model estimates a fair value of $0.0067 versus a price of $0.0049, about +37% upside (undervalued).
What is the fair value of TGIFF?
Our model-based fair value for 1933 Industries Inc is $0.0067 (as of Nov 13, 2026), built from audited fundamentals. The current price: $0.0049.
What is the quality score of TGIFF?
1933 Industries Inc has a Quality Score of 51/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for 1933 Industries Inc (TGIFF)?
Our model-based price target is the fair value of $0.0067 (as of Nov 13, 2026) from 10 valuation models. Cautious scenario $0.0067, optimistic scenario $0.0073. It is a calculation from audited fundamentals, not an analyst target.
What is the 1933 Industries Inc stock forecast for 2026?
Our models put fair value at $0.0067, about +37% upside versus a price of $0.0049 (undervalued). Cautious scenario $0.0067, optimistic scenario $0.0073. The calculation is refreshed regularly with new filings.
What is the revenue of 1933 Industries Inc (TGIFF)?
1933 Industries Inc reported trailing-twelve-month revenue of about C$16.5M (latest available figure, as of Nov 13, 2026).
What growth is priced into 1933 Industries Inc (TGIFF)?
Today's price is already fair in a discounted-cash-flow model if free cash flow at 1933 Industries Inc shrinks by 10.4 % per year for five years (discount rate 11.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew 7.8 % per year. As of Nov 13, 2026.
What discount rate (WACC) does the fair value of TGIFF use?
Our models discount 1933 Industries Inc at 11.0 %: a base by market capitalisation (nano), damped by beta 1.50, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For 1933 Industries Inc that is -10.4 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.0 %) and the same formula as our fair value.
How much growth has 1933 Industries Inc (TGIFF) delivered so far?
Over the past 5 years revenue at 1933 Industries Inc grew 7.8 % a year. The price currently implies free-cash-flow growth of -10.4 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of 1933 Industries Inc (TGIFF) growing?
The median revenue growth in the sector is +7.3 % a year. That is the yardstick for the growth priced into 1933 Industries Inc (-10.4 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of 1933 Industries Inc (TGIFF)?
The free-cash-flow yield on the price is 48.06 %: that much free cash flow 1933 Industries Inc produces per unit of market value. When it exceeds the discount rate of our models (11.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of 1933 Industries Inc (TGIFF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For 1933 Industries Inc it is $0.0067 per share (as of Nov 13, 2026), against a price of $0.0049. It is the blended result of 10 valuation models in 3 families (DCF Models, Multiples, Growth DCF).
Is 1933 Industries Inc stock overvalued or undervalued in 2026?
As of Nov 13, 2026, TGIFF trades below its calculated fair value: price $0.0049, fair value $0.0067, a gap of about +37% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of TGIFF?
No. The price is what the market pays today ($0.0049); the fair value is what the company's own numbers justify ($0.0067). For 1933 Industries Inc the two are $0.0018 per share apart. That gap is exactly why we show both numbers side by side.
How much is 1933 Industries Inc worth?
The market values 1933 Industries Inc at about $2.6M (market capitalisation, as of Nov 13, 2026). Per share that is $0.0049; our models calculate a fair value of $0.0067 per share.
What do the bullish and bearish scenarios say about TGIFF?
Our models span a range for 1933 Industries Inc: cautious scenario $0.0067, base $0.0067, optimistic $0.0073 per share (as of Nov 13, 2026, price $0.0049). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of 1933 Industries Inc (TGIFF)?
Balance-sheet figures for 1933 Industries Inc (as of Nov 13, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 51/100, which measures business quality independently of the share price.
How far is TGIFF from its 52-week high?
1933 Industries Inc trades at $0.0049, about 65% below its 52-week high of $0.0140 and 26% above the low of $0.0039 (as of Nov 13, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0067 is for.
Which stocks are comparable to 1933 Industries Inc?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Limited, Galderma Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is 1933 Industries Inc stock attractive at the current price?
The data as of Nov 13, 2026: price $0.0049, calculated fair value $0.0067 (+37%), Quality Score 51/100, from 10 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of TGIFF calculated?
We run 1933 Industries Inc through 10 models from 3 families: DCF Models, Multiples, Growth DCF. Every model gets the same audited fundamentals; the fair value of $0.0067 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5% above its aggregate fair value. 1933 Industries Inc currently trades 27% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of 1933 Industries Inc (TGIFF)?
The closing price on Nov 13, 2026 was $0.0049. Our model-based fair value is $0.0067, about +37% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with 1933 Industries Inc right now?
The price is below even our cautious bear case ($0.0067). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (51/100) at a price below fair value, the discount is the argument here, not the business quality. The models converge in a tight band ($0.0067 to $0.0073), unusually little disagreement for a valuation.

Key figures of 1933 Industries Inc

How large is the market capitalisation of 1933 Industries Inc (TGIFF)?
The market capitalisation of 1933 Industries Inc is $2.6M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of 1933 Industries Inc (TGIFF)?
The price-to-sales ratio of 1933 Industries Inc is 0.21 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of 1933 Industries Inc (TGIFF)?
The net margin of 1933 Industries Inc is −1.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of 1933 Industries Inc (TGIFF)?
The return on equity (ROE) of 1933 Industries Inc is −1,143% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of 1933 Industries Inc (TGIFF)?
On an EBIT basis the return on assets of 1933 Industries Inc is −17.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of 1933 Industries Inc (TGIFF)?
The operating margin of 1933 Industries Inc is 8.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at 1933 Industries Inc (TGIFF)?
Revenue at 1933 Industries Inc is down 9.3% versus a year earlier (3y avg +11.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at 1933 Industries Inc (TGIFF)?
Earnings per share at 1933 Industries Inc are down 6.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does 1933 Industries Inc (TGIFF) carry?
The net debt of 1933 Industries Inc is C$2.9M (fiscal year 2025, ≈ 1.7 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch 1933 Industries Inc in the live analysis

One click puts 1933 Industries Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.